CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,214 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00772369
NCT00772369N/ACompleted

Retrospective Safety Survey of Selected Events in the 6 Months Following the 4th Dose of the Pentacel® Vaccination Series in Children

Sanofi Pasteur, a Sanofi Company·observational·Posted Oct 15, 2008·Updated Feb 14, 2014

In Brief

An observational study for Diphtheria and 4 related conditions. Completed, enrolled 3,214 participants across 1 site.

Detailed Summary

The purpose of this survey is to collect selected safety data. Primary Objective: To collect selected safety data at 6 months following the 4th dose of the Pentacel® series.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 15, 2008
Enrollment StartSep 1, 2003
Primary CompletionApr 1, 2004
Study CompletionApr 1, 2005
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 17.7 years ago